Reports on prolactin (PRL) secretion in diabetes mellitus are few and controversial. PRL levels were found normal or elevated in diabetes (Hunter, Anderson, Lunn, Horrobin, Boyns and Cole 1974;Naeije, Badawi, Vanhaelst, Cornil and L'Hermite 1979). In the present study we have compared PRL responses to TRH and metoclopramide (MCP) in non-insulin dependent diabetes mellitus (NIDDM).
Material and Methods10 Non obese diabetics (7 men and 3 women, mean age 54.2 years) with recently diagnosed NIDDM were studied prior to the commencement of the treatment. 23 Healthy subjects (8 men and 15 women, mean age 39.4 years) served as the controls. The tests were performed between 8 and 9 a.m. after an overnight fast. The subjects were given TRH (Relefact, Hoechst) 200 ug iv. and metoclopramide (Metoclopramid, Polfa) 10 mg orally in a randomised fashion. Prolactin was measured in serum by the homologous specific RIA with the use of second antibody for separation (Jeske 1979). The sensitivity was 0.3 ng/ml and the normal values (x ± SD) were: 15.4 ng/ml ± 5.1 ng/ml. Student's t test was used to determine statistical significance.